Evidence map›Paper›PMID 29322240›Full record

ReviewChromosoma2018

Ki-67: more than a proliferation marker.

Xiaoming Sun, Paul D Kaufman

Abstract readReview
In one paragraph

Review in Chromosoma, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 506 papers, 3 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
506citing papers in PubMed, 3 pooled it
22.2field-weighted citation impact, top 1% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

506 citing papers in PubMed, 3 syntheses or guidelines pooled it, 952 citations in OpenAlex.

  1. Pooled it
  2. Pooled it
  3. Pooled it
  4. Endothelial Matrin-3 Limits Cellular Senescence and Lipid Dysregulation to Protect Against Murine Atherosclerosis.FASEB journal : official publication of the Federation of American Societies for Experimental Biology · 2026
    Article
  5. Review
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Article
  12. Article
  13. Article
  14. Article
  15. Cancers · 2026
    Article
  16. Article
  17. Review
  18. Article
  19. Article
  20. Article

446 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

2 authors at 1 institution in 1 country.

Xiaoming SunDepartment of Molecular, Cell and Cancer Biology, University Massachusetts Medical School, 364 Plantation St. #506, Worcester, MA, 01605, USA.
Paul D KaufmanDepartment of Molecular, Cell and Cancer Biology, University Massachusetts Medical School, 364 Plantation St. #506, Worcester, MA, 01605, USA. paul.kaufman1@umassmed.edu.
University of Massachusetts Chan Medical School · US

Funding

Nucleolar Genomics During Early Mammalian DevelopmentU01DA040588 · NIDA · UNIV OF MASSACHUSETTS MED SCH WORCESTER · PI KAUFMAN, PAUL D., PEDERSON, THORU · 2015 to 2019
$2.2M
Eukaryotic Nuclear Functions: from Nucleosomes to ChromosomesR35GM127035 · NIGMS · UNIV OF MASSACHUSETTS MED SCH WORCESTER · PI KAUFMAN, PAUL D. · 2018 to 2022
$1.8M
NIDA NIH HHS U01 DA040588NIGMS NIH HHS R35 GM127035
6 · The paper itself

Abstract

Ki-67 protein has been widely used as a proliferation marker for human tumor cells for decades. In recent studies, multiple molecular functions of this large protein have become better understood. Ki-67 has roles in both interphase and mitotic cells, and its cellular distribution dramatically changes during cell cycle progression. These localizations correlate with distinct functions. For example, during interphase, Ki-67 is required for normal cellular distribution of heterochromatin antigens and for the nucleolar association of heterochromatin. During mitosis, Ki-67 is essential for formation of the perichromosomal layer (PCL), a ribonucleoprotein sheath coating the condensed chromosomes. In this structure, Ki-67 acts to prevent aggregation of mitotic chromosomes. Here, we present an overview of functional roles of Ki-67 across the cell cycle and also describe recent experiments that clarify its role in regulating cell cycle progression in human cells.

Indexed as

MitosisAmino Acid SequenceCell Line, TumorCell NucleolusCell ProliferationCyclin-Dependent Kinase Inhibitor p21Gene Expression RegulationHeterochromatinHumansInterphaseKi-67 AntigenProtein DomainsProtein IsoformsRetinoblastoma ProteinRibonucleoproteinsTumor Suppressor Protein p53Cyclin-Dependent Kinase Inhibitor p21HeterochromatinKi-67 AntigenProtein IsoformsRetinoblastoma ProteinRibonucleoproteinsTumor Suppressor Protein p53Cell cycleHeterochromatinKi-67Perichromosomal layer

Identifiers

PMID29322240
PMCPMC5945335
OpenAlexW2783197533

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.